Sugammadex is extensively used since its introduction to our country in 2010; however, there is a paucity of data showing its optimal dose for reversal of neuromuscular blockade, particularly shortly… Click to show full abstract
Sugammadex is extensively used since its introduction to our country in 2010; however, there is a paucity of data showing its optimal dose for reversal of neuromuscular blockade, particularly shortly after administration of muscle relaxants. Either the dose of rocuronium for reparalysis after reversal by sugammadex in the immediate postoperative period has not been studied in detail. In recent issues of Journal of Anesthesia, outstanding anesthesiologists have brought us critical information regarding these issues by novel methods [1–3], which will add new aspects on the preexisting knowledge and contribute to the daily clinical practice.
               
Click one of the above tabs to view related content.